한글목차

세계의 마크로파지 마커 시장은 2025년 2억 9,030만 달러로 추정되고, 2032년까지 4억 5,110만 달러에 이를 것으로 예측되며, 2025년부터 2032년까지 CAGR 6.5%로 성장할 전망입니다.

마크로파지는 면역과 항상성 유지에 중요한 역할을 하는 백혈구입니다. 마크로파지는 이물질, 미생물, 잔해를 섭취하는 첫 번째 반응자 역할을합니다. 그 중요성 때문에 마크로파지의 생물학적 특성을 밝히고 연구하는 것이 필수적입니다. 마크로파지 마커를 통해 연구자는 이러한 세포를 확인, 분리, 추적 및 표적화할 수 있습니다. 마크로파지 마커는 주로 두 가지 유형이 있습니다. 하나는 세포 표면 마커로, 마크로파지의 외막에 발현하는 단백질이며, 형광 활성화 세포 선별법이나 면역조직화학법을 이용하여 검출할 수 있습니다. 일반적인 마크로파지 세포 표면 마커에는 CD68, CD14, CD163, CD206 등이 있습니다. 다른 하나는 세포 내 마커이며 마크로파지 세포에 존재하는 단백질입니다.

세포 내 마커는 마크로파지 활성화 및 기능에 대한 정보를 제공하지만 세포를 고정하고 투과 처리해야합니다. 세포 표면 마커는 마크로파지의 살아있는 세포 분석, 분리 및 표적화가 가능하다는 장점이 있습니다. 그러나 마크로파지를 고유하게 식별할 수 있을 만큼 특이적인 마커는 없으며, 마커의 발현은 활성화 상태 및 조직 환경에 따라 변합니다. 마크로파지의 표현형과 개체군을 정확하게 특성화하려면 여러 마커를 결합하는 것이 이상적입니다. 세계 시장에서는 마크로파지 마커에 대한 다양한 단일클론항체가 제공되고 있으며, 병리에 상관없이 새로운 치료 전략을 모색하는 기초 연구와 응용 연구에 도움이 되고 있습니다.

시장 역학

• 면역학 연구 증가, 만성 질환 유병률 증가, 기술 진보, 맞춤형 의료 접근법은 예측 기간 동안 마크로파지 마커 세계 시장 성장을 가속할 것으로 예상되는 주요 요인입니다.
• 예를 들어 2022년 6월에 국립생물공학정보센터가 발표한 보고서에 따르면 인도에서는 고령자의 약 21%가 적어도 하나의 만성질환을 안고 있다고 보고되었습니다.
• 한편, 2020년 12월에 국제암 대책연합이 발표한 보고서에 의하면, 세계 전체에서는 평생 가운데 5명에 1명이 암에 걸려, 남성의 8명에 1명, 여성의 11명에 1명이 암으로 사망하고 있습니다.
• 그러나, 마크로파지의 불균일성의 복잡성, 특이성과 감도의 부족, 유효한 항체의 한정된 이용 가능성이, 예측 기간중 세계의 마크로파지 마커 시장의 성장을 방해할 것으로 예측됩니다.

본 조사의 주요 특징

• 본 보고서에서는 세계의 마크로파지 마커 시장을 상세하게 분석하여 2024년을 기준연도로 한 예측기간 2025-2032년 시장 규모와 연간 평균 성장률(CAGR%)을 제공합니다.
• 또, 다양한 부문에 걸친 잠재적인 수익 기회를 밝혀, 이 시장의 매력적인 투자 제안 매트릭스에 대해서 해설했습니다.
• 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품의 상시나 승인, 시장 동향, 지역에 의한 전망, 주요 기업이 채용하는 경쟁 전략 등에 관한 중요한 고찰도 제공합니다.
• 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등의 파라미터에 근거해, 세계의 마크로파지 마커 시장의 주요 기업 프로파일을 제공합니다.
• 본 보고서로부터 통찰에 의해 마케팅 담당자나 기업의 경영진은 장래의 제품 발매, 유형, 시장 확대, 마케팅 전술에 관한 정보에 근거한 의사 결정을 실시할 수 있습니다.
• 세계의 마크로파지 마커 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 참가자, 재무 분석가 등 이 산업의 다양한 이해 관계자에 대응하고 있습니다.
• 이해관계자들은 세계의 마크로파지 마커 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정이 용이해집니다.

목차

제1장 조사의 목적과 전제조건

• 조사 목적
• 전제조건
• 약어

제2장 시장 전망

• 보고서 설명
  • 시장 정의와 범위
• 주요 요약
• Coherent Opportunity Map (COM)

제3장 시장 역학, 규제, 동향 분석

• 시장 역학
  • 성장 촉진요인
  • 억제요인
  • 기회
• 영향 분석
• 규제 시나리오
• 제품 출시/승인
• PEST 분석
• Porter's Five Forces 분석
• 합병과 인수 시나리오

제4장 세계의 마크로파지 마커 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향

• COVID-19 역학
• 공급측과 수요측의 분석
• 경제에 미치는 영향

제5장 세계의 마크로파지 마커 시장 : 마커 유형별, 2020-2032년

• 소개
• CD68
• CD163
• CD206
• CD14
• CD11b
• CD64
• CD11c
• 기타

제6장 세계의 마크로파지 마커 시장 : 용도별, 2020-2032년

• 소개
• 연구 용도
• 진단 용도
• 의약품 개발

제7장 세계의 마크로파지 마커 시장 : 질환 영역별, 2020-2032년

• 소개
• 종양학
• 감염증
• 자가면역질환
• 심혈관 질환
• 신경질환
• 기타

제8장 세계의 마크로파지 마커 시장 : 최종 사용자별, 2020-2032년

• 소개
• 연구기관 및 학술센터
• 제약 및 생명 공학 기업
• 임상 및 진단 실험실
• 기타

제9장 세계의 마크로파지 마커 시장 : 지역별, 2020-2032년

• 소개
• 북미
  • 미국
  • 캐나다
• 유럽
  • 독일
  • 영국
  • 스페인
  • 프랑스
  • 이탈리아
  • 러시아
  • 기타 유럽
• 아시아태평양
  • 중국
  • 인도
  • 일본
  • 호주
  • 한국
  • ASEAN 국가
  • 기타 아시아태평양
• 라틴아메리카
  • 브라질
  • 아르헨티나
  • 멕시코
  • 기타 라틴아메리카
• 중동
  • GCC 국가
  • 이스라엘
  • 기타 중동
• 아프리카
  • 남아프리카
  • 북아프리카
  • 중앙 아프리카

제10장 경쟁 구도

• Abcam plc
• Bio-Rad Laboratories, Inc.
• Cell Signaling Technology, Inc.
• BD Biosciences
• Thermo Fisher Scientific, Inc.
• Agilent Technologies, Inc.
• BioLegend, Inc.
• Merck KGaA
• Novus Biologicals, LLC
• R&D Systems, Inc.(Bio-Techne 브랜드)
• Santa Cruz BIoTechnology, Inc.
• Beckman Coulter, Inc.
• Miltenyi BIoTec GmbH
• GeneTex, Inc.
• MBL International Corporation

제11장 섹션

• 조사 방법
• 출판사에 대해

영문목차

Macrophage Marker Market is estimated to be valued at USD 290.3 Mn in 2025 and is expected to reach USD 451.1 Mn by 2032, growing at a compound annual growth rate (CAGR) of 6.5% from 2025 to 2032.

Macrophages are white blood cells that play a key role in immunity and homeostasis. They act as first responders, ingesting foreign materials, microbes, and debris. Due to their importance, it is essential to characterize and study macrophage biology. Macrophage markers allow researchers to identify, isolate, track, and target these cells. There are two main types of macrophage markers. The first are cell surface markers, which are proteins expressed on the outer membrane of macrophages that can be detected using fluorescence-activated cell sorting or immunohistochemistry techniques. Common macrophage cell surface markers include CD68, CD14, CD163, and CD206. The second type are intracellular markers, which are proteins located inside macrophage cells.

Intracellular markers provide information about macrophage activation and function but require fixed and permeabilized cells. Cell surface markers have the advantage of allowing live cell analysis, isolation, and potentially targeting of macrophages. However, no single marker is specific enough to uniquely identify macrophages, and marker expression can change depending on activation state and tissue environment. Ideally, a combination of several markers is used to accurately characterize macrophage phenotypes and populations. The global market offers a wide variety of monoclonal antibodies against macrophage markers, aiding fundamental and applied research seeking new treatment strategies across medical conditions.

Market Dynamics

• Increasing research in immunology, the growing prevalence of chronic diseases, technological advancements, and personalized medicine approaches are major factors expected to drive growth of the global macrophage marker market during the forecast period.
• For instance, in June 2022, according to a report published by the National Center for Biotechnology information, approximately 21% of the elderly in India reportedly have at least one chronic disease.
• While, in December 2020, according to a report published by the Union for International Cancer Control, globally, 1 in 5 people develop cancer during their lifetime, and 1 in 8 men and 1 in 11 women die from the disease.
• However, the complexity of macrophage heterogeneity, a lack of specificity and sensitivity, and the limited availability of validated antibodies are expected to hamper growth of the global macrophage marker market over the forecast period.

Key features of the study:

• This report provides in-depth analysis of the global macrophage marker market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global macrophage marker market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Abcam plc, Bio-Rad Laboratories, Inc., Cell Signaling Technology, Inc., BD Biosciences, Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., BioLegend, Inc., Merck KGaA, Novus Biologicals, LLC, R&D Systems, Inc. (a Bio-Techne brand), Santa Cruz Biotechnology, Inc., Beckman Coulter, Inc., Miltenyi Biotec GmbH, GeneTex, Inc., MBL International Corporation.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global macrophage marker market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global macrophage marker market

Macrophage Marker Market Detailed Segmentation:

• By Marker Type:
  • CD68
  • CD163
  • CD206
  • CD14
  • CD11b
  • CD64
  • CD11c
  • Others
• By Application:
  • Research Use
  • Diagnostic Use
  • Drug Development
• By Disease Area:
  • Oncology
  • Infectious Diseases
  • Autoimmune Diseases
  • Cardiovascular Diseases
  • Neurological Disorders
  • Others
• By End User:
  • Research Institutes and Academic Centers
  • Pharmaceutical and Biotechnology Companies
  • Clinical and Diagnostic Laboratories
  • Others
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles
  • Abcam plc
  • Bio-Rad Laboratories, Inc.
  • Cell Signaling Technology, Inc.
  • BD Biosciences
  • Thermo Fisher Scientific, Inc.
  • Agilent Technologies, Inc.
  • BioLegend, Inc.
  • Merck KGaA
  • Novus Biologicals, LLC
  • R&D Systems, Inc. (a Bio-Techne brand)
  • Santa Cruz Biotechnology, Inc.
  • Beckman Coulter, Inc.
  • Miltenyi Biotec GmbH
  • GeneTex, Inc.
  • MBL International Corporation

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Macrophage Marker, By Marker Type
  • Market Macrophage Marker, By Application
  • Market Macrophage Marker, By Disease Area
  • Market Macrophage Marker, By End User
  • Market Macrophage Marker, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Driver
  • Restraint
  • Opportunity
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Macrophage Marker Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Macrophage Marker Market, By Marker Type, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021-2032
  • Segment Trends
• CD68
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• CD163
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• CD206
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• CD14
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• CD11b
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• CD64
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• CD11c
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

6. Global Macrophage Marker Market, By Application, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021-2032
  • Segment Trends
• Research Use
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Diagnostic Use
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Drug Development
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

7. Global Macrophage Marker Market, By Disease Area, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021- 2032
  • Segment Trends
• Oncology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Infectious Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Autoimmune Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Cardiovascular Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Neurological Disorders
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

8. Global Macrophage Marker Market, By End User, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021- 2032
  • Segment Trends
• Research Institutes and Academic Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Pharmaceutical and Biotechnology Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Clinical and Diagnostic Laboratories
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

9. Global Macrophage Marker Market, By Region, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, By Country, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Country 2021-2028
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Marker Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Area, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Marker Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Area, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Marker Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Area, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Marker Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Area, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Marker Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Area, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Marker Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Area, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Mn)
    • South Africa
    • North Africa
    • Central Africa

10. Competitive Landscape

• Abcam plc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Bio-Rad Laboratories, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Cell Signaling Technology, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• BD Biosciences
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Thermo Fisher Scientific, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Agilent Technologies, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• BioLegend, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Merck KGaA
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Novus Biologicals, LLC
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• R&D Systems, Inc. (a Bio-Techne brand)
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Santa Cruz Biotechnology, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Beckman Coulter, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Miltenyi Biotec GmbH
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• GeneTex, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• MBL International Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Analyst Views

11. Section

• Research Methodology
• About us